Correlation Between Gelesis Holdings and Scopus Biopharma
Can any of the company-specific risk be diversified away by investing in both Gelesis Holdings and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gelesis Holdings and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gelesis Holdings and Scopus Biopharma, you can compare the effects of market volatilities on Gelesis Holdings and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gelesis Holdings with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gelesis Holdings and Scopus Biopharma.
Diversification Opportunities for Gelesis Holdings and Scopus Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Gelesis and Scopus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Gelesis Holdings and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Gelesis Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gelesis Holdings are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Gelesis Holdings i.e., Gelesis Holdings and Scopus Biopharma go up and down completely randomly.
Pair Corralation between Gelesis Holdings and Scopus Biopharma
If you would invest 10.00 in Scopus Biopharma on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Scopus Biopharma or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Gelesis Holdings vs. Scopus Biopharma
Performance |
Timeline |
Gelesis Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Gelesis Holdings and Scopus Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gelesis Holdings and Scopus Biopharma
The main advantage of trading using opposite Gelesis Holdings and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gelesis Holdings position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.Gelesis Holdings vs. Triton International Limited | Gelesis Holdings vs. U Haul Holding | Gelesis Holdings vs. HE Equipment Services | Gelesis Holdings vs. Datadog |
Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |